Torres Denice 4/A

What Happened Denice Torres, a director of GLAUKOS Corp (GKOS), was granted a derivative award on 2026-05-28 covering 2,987 shares (options) with an exercise price of $106.52. The Form 4A filed 2026-06-23 amends an earlier Form 4 to correct the exercise price (previously reported as $53.57). The grant was reported as an acquisition (code A) and vests in full on the one-year anniversary of the grant.

Key Details

• Transaction date: 2026-05-28 (reported via amended Form 4 on 2026-06-23).
• Award: 2,987 option rights; exercise price: $106.52 per share (corrected from $53.57).
• Consideration reported at grant: $0 (typical for equity awards; this is not an open‑market purchase).
• Vesting: Vests in full one year after grant date (per issuer’s Director Compensation Policy).
• Ownership after transaction: Not specified in the information provided.
• Filing status: Amended Form 4; original Form 4 (filed June 1) contained the incorrect exercise price — amendment improves accuracy but the report was filed after the transaction date.

Context This was a director compensation grant (routine for non-employee directors) rather than a market purchase or sale. As a derivative award, no shares were sold or bought immediately — Torres will have the right to exercise these options in the future at $106.52 per share if and when vested and exercised, which could dilute shares if exercised. The amendment corrected the strike price, improving transparency for investors; the filing was submitted after the transaction date.